Home › Multiple Myeloma › California › Santa Monica
Multiple Myeloma clinical trials in Santa Monica, CA
8 studies for Multiple Myeloma are looking for participants at sites in and around Santa Monica (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
RecruitingPhase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mi away
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RecruitingPhase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mi away
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi away
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mi away
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RecruitingPhase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
RecruitingPhase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mi away
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RecruitingPhase 3
- GSK Investigational Site, Beverly Hills · 6 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Rochester, MN24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Washington, DC22 studies
Other studies in Santa Monica
- Non-Small Cell Lung Cancer45 studies
- Breast Cancer27 studies
- Colorectal Cancer23 studies
- Cancer (all types)20 studies
- Metastatic Cancer19 studies
- Lung Cancer15 studies
- Prostate Cancer15 studies
- Ovarian Cancer15 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Heart Failure11 studies
- Endometrial Cancer10 studies
- Melanoma8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.